Literature DB >> 33170430

Silencing of lncRNA DLEU1 inhibits tumorigenesis of ovarian cancer via regulating miR-429/TFAP2A axis.

Huiying Xu1, Lingyan Wang2, Xiuli Jiang3.   

Abstract

Long non-coding RNAs (lncRNAs) are known as crucial regulators in the development of OC. In the current study, we aim to explore the function and molecular mechanism of lncRNA DLEU1 in OC. Quantitative real-time polymerase chain reaction (qRT-PCR) was applied to determine the expression of DLEU1, miR-429, and TFAP2A in OC cells and tissues. The relationship among DLEU1, miR-429, and TFAP2A was tested by dual-luciferase reporter (DLR) assay. Besides, the proliferative, migratory and invasive abilities of OC cells were analyzed by MTT, wound healing, and transwell assays, respectively. Western blot was performed to determine the protein expression of TFAP2A. The expression of lncRNA DLEU1 and TFAP2A were upregulated, and miR-429 was downregulated in OC tissues. Silencing of DLEU1 inhibited the proliferation, migration, and invasion of OC cells. Bioinformation and DLR assay showed that DLEU1 acted as the sponge for miR-429. Moreover, miR-429 could directly target TFAP2A and inhibit the proliferation, migration, and invasion of OC cells. Moreover, we observed a negative correlation between miR-429 and DLEU1, and between miR-429 and TFAP2A in OC tissues. The transfection of miR-429 inhibitor or pcDNA-TFAP2A reversed the inhibitory effects of si-DLEU1 on the proliferation, migration, and invasion of OC cells. Silencing of DLEU1 inhibited the proliferation, migration, and invasion of OC cells by regulating miR-429/TFAP2A axis, indicating a potential therapeutic target for OC.

Entities:  

Keywords:  Long non-coding RNA DLEU1; MicroRNAs; Ovarian cancer; TFAP2A; miR-429

Mesh:

Substances:

Year:  2020        PMID: 33170430     DOI: 10.1007/s11010-020-03971-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  24 in total

1.  High-performance liquid chromatographic separation of human apotransferrin and monoferric and diferric transferrins.

Authors:  Y Makino; E Kawanishi
Journal:  J Chromatogr       Date:  1991-06-14

2.  MicroRNA-9 promotes tumorigenesis and mediates sensitivity to cisplatin in primary epithelial ovarian cancer cells.

Authors:  Hong-Min Zhao; Wei Wei; Yu-Hui Sun; Jian-Hua Gao; Qi Wang; Jian-Hua Zheng
Journal:  Tumour Biol       Date:  2015-04-07

3.  Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5.

Authors:  Hongmin Zhao; Hongli Yu; Jianhua Zheng; Ning Ning; Fanglan Tang; Yang Yang; Yan Wang
Journal:  Gynecol Oncol       Date:  2018-09-07       Impact factor: 5.482

4.  The overexpression of lncRNA MEG3 inhibits cell viability and invasion and promotes apoptosis in ovarian cancer by sponging miR-205-5p.

Authors:  Pingping Tao; Binlie Yang; Huiya Zhang; Liyan Sun; Yungen Wang; Weiping Zheng
Journal:  Int J Clin Exp Pathol       Date:  2020-05-01

5.  LncRNA LINC00319 accelerates ovarian cancer progression through miR-423-5p/NACC1 pathway.

Authors:  Wenling Du; Zejiao Feng; Qinqin Sun
Journal:  Biochem Biophys Res Commun       Date:  2018-11-12       Impact factor: 3.575

6.  LncRNA HOXA11-AS promotes proliferation and invasion by targeting miR-124 in human non-small cell lung cancer cells.

Authors:  Wanjun Yu; Weidong Peng; Hao Jiang; Hanyun Sha; Jipeng Li
Journal:  Tumour Biol       Date:  2017-10

7.  Downregulation of miR-429 contributes to the development of drug resistance in epithelial ovarian cancer by targeting ZEB1.

Authors:  Jing Zou; Ling Liu; Qi Wang; Fuqiang Yin; Zhijun Yang; Wei Zhang; Li Li
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

8.  The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9.

Authors:  Xiaoqian Wang; Bing Yang; Yuanping She; Yuan Ye
Journal:  J Cell Biochem       Date:  2018-06-15       Impact factor: 4.429

9.  LncRNA LUCAT1 promotes proliferation of ovarian cancer cells by regulating miR-199a-5p expression.

Authors:  H-Z Liu; G-Y Liu; W-W Pang; H Zhang; Z-J Zeng; H-J Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-02       Impact factor: 3.507

10.  KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells.

Authors:  Hong Chen; Bairong Xia; Tianbo Liu; Mei Lin; Ge Lou
Journal:  Cancer Cell Int       Date:  2016-09-26       Impact factor: 5.722

View more
  5 in total

1.  Landscape and Construction of a Novel N6-methyladenosine-related LncRNAs in Cervical Cancer.

Authors:  Xin Liu; Weijie Zhang; Jun Wan; Diming Xiao; Ming Wei
Journal:  Reprod Sci       Date:  2022-09-08       Impact factor: 2.924

2.  The expression level of chicken telomerase reverse transcriptase in tumors induced by ALV-J is positively correlated with methylation and mutation of its promoter region.

Authors:  Yong Xiang; Qinxi Chen; Qingbo Li; Canxin Liang; Weisheng Cao
Journal:  Vet Res       Date:  2022-06-23       Impact factor: 3.829

Review 3.  Metastatic EMT Phenotype Is Governed by MicroRNA-200-Mediated Competing Endogenous RNA Networks.

Authors:  Sara Uhan; Nina Hauptman
Journal:  Cells       Date:  2021-12-28       Impact factor: 6.600

4.  LncRNA DLEU1 is overexpressed in premature ovarian failure and sponges miR-146b-5p to increase granulosa cell apoptosis.

Authors:  Caihong Zheng; Shiwei Liu; Zhihong Qin; Xiaoqian Zhang; Yubao Song
Journal:  J Ovarian Res       Date:  2021-11-05       Impact factor: 4.234

5.  Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.

Authors:  Xiang Ding; Xu Xu; Xue-Feng He; Ye Yuan; Chuang Chen; Xin-Yu Shen; Sai Su; Zhang Chen; Song-Tao Xu; Yu-Hua Huang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.